Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Mar;10(3):374-94.
doi: 10.1016/j.molonc.2016.01.007. Epub 2016 Jan 28.

Circulating tumor cell technologies

Affiliations
Review

Circulating tumor cell technologies

Meghaan M Ferreira et al. Mol Oncol. 2016 Mar.

Abstract

Circulating tumor cells, a component of the "liquid biopsy", hold great potential to transform the current landscape of cancer therapy. A key challenge to unlocking the clinical utility of CTCs lies in the ability to detect and isolate these rare cells using methods amenable to downstream characterization and other applications. In this review, we will provide an overview of current technologies used to detect and capture CTCs with brief insights into the workings of individual technologies. We focus on the strategies employed by different platforms and discuss the advantages of each. As our understanding of CTC biology matures, CTC technologies will need to evolve, and we discuss some of the present challenges facing the field in light of recent data encompassing epithelial-to-mesenchymal transition, tumor-initiating cells, and CTC clusters.

Keywords: Antigen-independent enrichment; CTC capture; CTC clusters; Cancer; Immunoaffinity enrichment.

PubMed Disclaimer

References

    1. Aceto, N. , Bardia, A. , Miyamoto, D.T. , Donaldson, M.C. , Wittner, B.S. , Spencer, J.A. , Yu, M. , Pely, A. , Engstrom, A. , Zhu, H. , Brannigan, B.W. , Kapur, R. , Stott, S.L. , Shioda, T. , Ramaswamy, S. , Ting, D.T. , Lin, C.P. , Toner, M. , Haber, D.A. , Maheswaran, S. , 2014. Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell. 158, 1110–1122. 10.1016/j.cell.2014.07.013 - DOI - PMC - PubMed
    1. Adams, D.L. , Martin, S.S. , Alpaugh, R.K. , Charpentier, M. , Tsai, S. , Bergan, R.C. , Ogden, I.M. , Catalona, W. , Chumsri, S. , Tang, C.-M. , Cristofanilli, M. , 2014. Circulating giant macrophages as a potential biomarker of solid tumors. PNAS. 111, 3514–3519. 10.1073/pnas.1320198111 - DOI - PMC - PubMed
    1. Adams, D.L. , Zhu, P. , Makarova, O.V. , Martin, S.S. , Charpentier, M. , Chumsri, S. , Li, S. , Amstutz, P. , Tang, C.-M. , 2014. The systematic study of circulating tumor cell isolation using lithographic microfilters. RSC Adv. 9, 4334–4342. 10.1039/C3RA46839A - DOI - PMC - PubMed
    1. Adams, D.L. , Stefansson, S. , Haudenschild, C. , Martin, S.S. , Charpentier, M. , Chumsri, S. , Cristofanilli, M. , Tang, C.M. , Alpaugh, R.K. , 2015. Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the CellSearch(®) CTC test. Cytometry A. 87, 137–144. 10.1002/cyto.a.22613 - DOI - PubMed
    1. Aktas, B. , Tewes, M. , Fehm, T. , Hauch, S. , Kimmig, R. , Kasimir-Bauer, S. , 2009. Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients. Breast Cancer Res. 11, R46 10.1186/bcr2333 - DOI - PMC - PubMed

Publication types